Comparar métodos

	CONSORT Checklist: Padrões para Relato de Ensaios Clínicos Randomizados	PRISMA Checklist: Padrões para Relato de Revisões Sistemáticas e Meta-análises
Área	Metodologia de pesquisa	Metodologia de pesquisa
Família	Process / pipeline	Process / pipeline
Ano de origem	2010 (original 1996)	2021 (original 2009)
Autor original	Schulz et al. (CONSORT Group)	Page et al. (PRISMA Group)
Tipo	Trial author reporting checklist	Systematic review author reporting checklist
Fonte seminal	Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. The Lancet, 375(9721), 1657–1668.	Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.
Outros nomes	CONSORT, CONSORT 2010	PRISMA, PRISMA 2020
Relacionados	4	4
Resumo	The CONSORT (Consolidated Standards of Reporting Trials) Statement is a 25-item evidence-based checklist and flow diagram developed to standardize reporting of parallel-group randomized controlled trials. First published in 1996 and updated in 2010 (CONSORT 2010), it is endorsed by over 600 journals including The Lancet, JAMA, and BMJ, and is mandatory or strongly recommended for RCT manuscript submission across clinical research.	PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility.